Physician profile
Nicholas E Peterson
NPI 1689230450
$4,453.20
in general payments reported to CMS, 2019-2025
17 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,267 · 2024: $2,881 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524 · Travel and Lodging: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.92 |
| Travel and Lodging | $1,929.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,400.38 | 2023-2024 | |
| Saluda Medical Americas, INC. | $419.04 | 2024 | Evoke |
| Catalyst Pharmaceuticals, INC. | $266.29 | 2024 | |
| Ge Healthcare | $207.23 | 2024-2025 | |
| Curonix LLC | $176.68 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $135.64 | 2024 | Senza |
| Ucb, INC. | $133.87 | 2024 | Nayzilam |
| Medtronic, INC. | $132.05 | 2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $124.00 | 2023 | Sprint Pns System |
| Alexion Pharmaceuticals, INC. | $104.77 | 2024 | Ultomiris |
| Life Molecular Imaging LTD | $90.57 | 2025 | Neuraceq |
| Abbvie INC. | $85.65 | 2024 | |
| International Rehabilitative Sciences, INC | $63.16 | 2025 | Rs-4i Plus With Intersperse |
| Lundbeck LLC | $33.57 | 2024 | Rexulti |
| Tonix Medicines, INC. | $27.16 | 2024 | Zembrace Symtouch |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $26.82 | 2025 | Sx-One Microknife |
| Ani Pharmaceuticals, INC. | $26.32 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.